$10.39
In chiusura: Oct 3, 4:37 PM EDT
$10.26
-0.13-1.25%
Pre-mercato: Oct 3, 4:37 PM EDT
Comments
Loading...
Guidance e previsioni
Amneal Pharmaceuticals fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/05/2025 | AMRX | Amneal Pharmaceuticals | FY | 2025 | $0.70 | $0.75 | $0.68 | $3.00B | $3.10B | $3.02B | |
07/21/2025 | AMRX | Amneal Pharmaceuticals | Q2 | 2025 | — | — | $0.17 | $720.00M | $730.00M | $749.64M | |
05/02/2025 | AMRX | Amneal Pharmaceuticals | FY | 2025 | $0.65 | $0.70 | $0.68 | $3.00B | $3.10B | $3.03B | |
02/28/2025 | AMRX | Amneal Pharmaceuticals | FY | 2025 | $0.65 | $0.70 | $0.71 | $3.00B | $3.10B | $2.92B | |
01/15/2025 | AMRX | Amneal Pharmaceuticals | FY | 2024 | $0.57 | $0.63 | $0.61 | $2.70B | $2.80B | $2.77B | |
11/08/2024 | AMRX | Amneal Pharmaceuticals | FY | 2024 | $0.57 | $0.63 | $0.60 | $2.70B | $2.80B | $2.76B | |
08/09/2024 | AMRX | Amneal Pharmaceuticals | FY | 2024 | $0.57 | $0.63 | $0.61 | $2.70B | $2.80B | $2.65B | |
05/03/2024 | AMRX | Amneal Pharmaceuticals | FY | 2024 | $0.53 | $0.63 | $0.58 | $2.55B | $2.65B | $2.61B | |
03/01/2024 | AMRX | Amneal Pharmaceuticals | FY | 2024 | $0.53 | $0.63 | $0.60 | $2.55B | $2.65B | $2.58B | |
11/07/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.51 | $0.58 | $0.55 | $2.37B | $2.42B | $2.37B | |
10/23/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.51 | $0.58 | $0.55 | $2.37B | $2.42B | $2.37B | |
10/23/2023 | AMRX | Amneal Pharmaceuticals | Q3 | 2023 | — | — | — | $610.00M | $620.00M | $585.69M | |
08/04/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.45 | $0.55 | $0.47 | $2.30B | $2.40B | $2.32B | |
05/05/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.40 | $0.50 | $0.50 | $2.25B | $2.35B | $2.32B | |
04/17/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.40 | $0.50 | $0.50 | $2.25B | $2.35B | $2.31B | |
04/17/2023 | AMRX | Amneal Pharmaceuticals | Q1 | 2023 | — | — | — | $550.00M | $560.00M | $529.47M | |
03/02/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.40 | $0.50 | $0.77 | $2.25B | $2.35B | $2.31B | |
01/10/2023 | AMRX | Amneal Pharmaceuticals | FY | 2022 | $0.65 | $0.70 | $0.66 | $2.15B | $2.25B | $2.18B | |
11/04/2022 | AMRX | Amneal Pharmaceuticals | FY | 2022 | $0.65 | $0.70 | $0.68 | $2.15B | $2.25B | $2.20B | |
08/05/2022 | AMRX | Amneal Pharmaceuticals | FY | 2022 | $0.65 | $0.70 | $0.81 | $2.15B | $2.25B | $2.17B | |
05/04/2022 | AMRX | Amneal Pharmaceuticals | FY | 2022 | $0.80 | $0.85 | $0.84 | $2.15B | $2.25B | $2.19B | |
03/02/2022 | AMRX | Amneal Pharmaceuticals | FY | 2022 | $0.80 | $0.85 | $0.90 | $2.15B | $2.25B | $2.17B | |
01/11/2022 | AMRX | Amneal Pharmaceuticals | FY | 2021 | $0.78 | $0.88 | $0.88 | $2.10B | $2.10B | $2.10B | |
11/03/2021 | AMRX | Amneal Pharmaceuticals | FY | 2021 | $0.78 | $0.88 | $0.88 | $2.10B | $2.10B | $2.14B | |
08/09/2021 | AMRX | Amneal Pharmaceuticals | FY | 2021 | $0.70 | $0.85 | $0.82 | $2.10B | $2.20B | $2.12B | |
05/07/2021 | AMRX | Amneal Pharmaceuticals | FY | 2021 | $0.70 | $0.85 | $0.78 | $2.10B | $2.20B | $2.14B | |
02/26/2021 | AMRX | Amneal Pharmaceuticals | FY | 2021 | $0.70 | $0.85 | $0.71 | $2.10B | $2.20B | $2.06B | |
01/12/2021 | AMRX | Amneal Pharmaceuticals | FY | 2020 | $0.55 | $0.65 | $0.62 | $1.95B | $2.00B | $1.99B |
FAQ
Qual è la guidance più recente per Amneal Pharmaceuticals (AMRX)?
Le ultime previsioni per Amneal Pharmaceuticals (AMRX) sono state riportate il agosto 5, 2025 per l'intero anno 2025. L'azienda ha fornito una previsione di utili per azione nell'intervallo da $0.70 a $0.75, rispetto all'EPS stimato di $0.68. Inoltre, Amneal Pharmaceuticals ha previsto ricavi tra $3.00B e $3.10B per il trimestre.
Sfoglia guidance e previsioni su tutte le azioni.